What an AGA Blood Test Can and Cannot Tell You — Reading Hormones, Thyroid, and Ferritin Properly2026.06.29

“If I do an AGA blood test, will the cause of my hair loss finally become clear?” Many patients arrive at our clinic with exactly this expectation. Blood is indeed a mirror of the body’s internal state, offering a precious window into hormone levels, nutritional status, and thyroid function as quantifiable numbers. Yet in daily AGA (androgenetic alopecia) practice, I find that unless we first organize what an AGA blood test can and cannot reveal, patients either become overly swayed by the numbers, or stop their investigation the moment they hear “all normal.”

Hair loss is shaped by overlapping factors: genetic predisposition, hormone receptor sensitivity, systemic condition, lifestyle, and scalp environment. A blood test only illuminates one layer of this. In this article, we organize from a clinical standpoint what an AGA blood test truly reveals, and how regenerative therapies such as stem cell conditioned media can address what blood numbers cannot.

What an AGA blood test can detect — and why it matters

When a patient suspecting AGA visits a medical institution, blood testing is not a mere routine. It serves to screen for systemic factors hidden behind the hair loss that may be accelerating it.

Androgen-related: Testosterone and Free Testosterone

A primary driver of AGA is the conversion of testosterone to dihydrotestosterone (DHT) by 5α-reductase, with DHT acting on hair follicles. Total and free testosterone are therefore sometimes measured. However, the critical point is that AGA can progress even when blood hormone values fall within the normal range — because what determines hair loss is not blood concentration itself, but the androgen receptor sensitivity at the follicle.

Thyroid Function: TSH, FT3, FT4

Both hypothyroidism and hyperthyroidism can cause diffuse hair loss. Especially in women presenting with “overall thinning” or “widening of the part line,” the cause may not be AGA or FAGA but thyroid-related shedding — a condition the blood test reliably picks up. Because thyroid hormones directly influence the hair cycle, stabilizing function with medication can dramatically improve shedding.

Iron and Ferritin: Detecting Hidden Iron Deficiency

Even with normal hemoglobin, low ferritin — the storage form of iron — is frequently seen, particularly in menstruating women. Low ferritin readily triggers telogen effluvium and represents one of the most actionable items in an AGA blood test. In women whose ferritin has dropped into single digits, iron replenishment alone can visibly reduce shedding within months.

Other Screening Items

Zinc, vitamin D, liver and kidney function, glucose, and lipid metabolism also indirectly affect the metabolic environment of the follicle. Zinc deficiency impairs keratin synthesis; vitamin D is suggested to participate in the hair cycle. Dyslipidemia and pre-diabetic states can compromise scalp microcirculation and nutrient delivery to the follicle.

What an AGA Blood Test Cannot See — Where Regenerative Medicine Has Room

Here is the heart of the matter. A widespread misunderstanding among patients is: “If the blood test is normal, AGA isn’t progressing” or “If blood is fine, no treatment is needed.” In reality, vast territories of AGA biology lie beyond the reach of blood testing, and hair loss often advances independently of blood values.

Androgen Receptor Sensitivity at the Follicle

As noted, even at the same blood DHT level, people with high follicular receptor sensitivity progress faster, and those with low sensitivity progress slower. This cannot be measured by standard insurance-level blood tests. As reflected in the guidelines of the Japanese Dermatological Association, AGA diagnosis is built primarily on history, visual inspection, and trichoscopy.

Scalp Microinflammation and the Follicular Microenvironment

Chronic perifollicular microinflammation, sebum balance, and disruption of the scalp microbiome are major background drivers of AGA — yet none can be evaluated by blood draw. These layers only emerge through visual examination and trichoscopy, and are entirely missed in a blood-test-only approach.

The Niche State of Hair Follicle Stem Cells

Whether hair follicle stem cells at the bulb are in a “working environment” cannot be captured by blood numbers. When aging, chronic inflammation, and oxidative stress fatigue the stem cell niche, regrowth slows even when hormone and nutritional markers are pristine. This is precisely where stem cell conditioned media can intervene.

For Patients Told “Everything’s Normal” — Stem Cell Conditioned Media as an Option

No notable findings on AGA blood testing, hormones and nutrition all within normal range — yet hair loss progresses. Such patients are far from rare; in fact, they form the most common pattern in our AGA outpatient clinic. When a clinician responds to “my part line is widening even though nothing shows up in blood” with “your bloodwork is normal, let’s just watch,” the patient is left bearing an unexplained anxiety while losing time.

Stem cell conditioned media contains a rich array of cytokines, growth factors, and exosomes released by mesenchymal stem cells during culture. Growth factors such as VEGF, IGF-1, HGF, and KGF have been reported to participate in follicular microvascular formation, hair matrix cell proliferation, and prolongation of the anagen phase. They act on the follicular microenvironment along a dimension entirely separate from blood values, making them a logically meaningful approach to “AGA that progresses despite normal bloodwork.”

At AVAN TOKYO, after first excluding systemic factors that blood testing can screen, we design treatment for residually progressing hair loss by combining microneedle RF via Morpheus8 with stem cell conditioned media drug delivery. Even when blood values are normal, lifting the environment around the follicle remains feasible.

How to Position the AGA Blood Test — A Clinical Proposal

An AGA blood test should be positioned not as “a single test that names the cause” but as “a screening that sifts out systemic factors requiring exclusion.” It is performed to catch conditions like hypothyroidism or iron deficiency, which, if overlooked, would otherwise dramatically improve with oral therapy or lifestyle guidance. Conversely, an absence of abnormalities in the blood does not mean hair loss will halt.

Only when the “systemic mirror” of blood, the “scalp mirror” of trichoscopy and visual inspection, and the “intervention into the follicular microenvironment” by stem cell conditioned media are combined, does AGA care become truly three-dimensional. Rather than “the bloodwork was normal, so we’ll do nothing,” we want patients to think: “because bloodwork could exclude systemic causes, we can now focus on the scalp.”

Do not face hair loss alone — please consult a specialist. Browse our related columns on hair regenerative medicine for further details on treatments and cases.

──────────────

[Supervising Physician] Shin Moriwaki (Supervising Doctor)

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

U.S. Medical Licensing Qualification (ECFMG certificate)

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries via DM / LINE / Website / Phone are welcome.